UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CT-based muscle and adipose measurements predict prognosis in patients with digestive system malignancy

Scientific reports, 2024-06, Vol.14 (1), p.13036-13

2024

Volltextzugriff (PDF)

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients

Molecular and clinical oncology, 2017-09, Vol.7 (3), p.498-506

2017

Volltextzugriff (PDF)

Nutritional features-based clustering analysis as a feasible approach for early identification of malnutrition in patients with cancer

European journal of clinical nutrition, 2021-08, Vol.75 (8), p.1291-1301

2021

Volltextzugriff (PDF)

Development and validation of an inflammatory biomarkers model to predict gastric cancer prognosis: a multi-center cohort study in China

BMC cancer, 2024-06, Vol.24 (1), p.711-13

2024

Volltextzugriff (PDF)

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists

Journal of translational medicine, 2023-02, Vol.21 (1), p.108-108, Article 108

2023

Volltextzugriff (PDF)

Mid-Arm Muscle Circumference or Body Weight-Standardized Hand Grip Strength in the GLIM Superiorly Predicts Survival in Chinese Colorectal Cancer Patients

Nutrients, 2022-12, Vol.14 (23), p.5166

2022

Volltextzugriff (PDF)

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events

Cancer biology & medicine, 2021-11, Vol.18 (4), p.1118-1133

2021

Volltextzugriff (PDF)

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

BMC cancer, 2021-01, Vol.21 (1), p.56-56, Article 56

2021

Volltextzugriff (PDF)

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359231187205-17588359231187205

2023

Volltextzugriff (PDF)

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy

Cancer medicine (Malden, MA), 2024-02, Vol.13 (3), p.e6855-n/a

2024

Volltextzugriff (PDF)

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003214

2021

Volltextzugriff (PDF)

A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice

Open medicine (Warsaw, Poland), 2022-01, Vol.17 (1), p.53-60

2022

Volltextzugriff (PDF)

Triceps skinfold–albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study

Journal of cachexia, sarcopenia and muscle, 2023-02, Vol.14 (1), p.517-533

2023

Volltextzugriff (PDF)

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e006055

2023

Volltextzugriff (PDF)

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial

Signal transduction and targeted therapy, 2024-09, Vol.9 (1), p.248-9, Article 248

2024

Volltextzugriff (PDF)

Zinc deficiency exacerbates diabetic down-regulation of Akt expression and function in the testis: essential roles of PTEN, PTP1B and TRB3

The Journal of nutritional biochemistry, 2012-08, Vol.23 (8), p.1018-1026

2012

Volltextzugriff (PDF)

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

Cancers, 2021-04, Vol.13 (8), p.1955

2021

Volltextzugriff (PDF)

High Visceral Fat in Female Breast Cancer Patients Correlates with the Risk of Progression after Adjuvant Chemotherapy

Nutrition and cancer, 2022-07, Vol.74 (6), p.2038-2048

2022

Volltextzugriff (PDF)

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

The lancet oncology, 2022-02, Vol.23 (2), p.220-233

2022

Volltextzugriff (PDF)

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (12), p.1223

2022

Volltextzugriff (PDF)

The clinical application value of the extracellular-water-to-total-body-water ratio obtained by bioelectrical impedance analysis in people with advanced cancer

Nutrition (Burbank, Los Angeles County, Calif.), 2022-04, Vol.96, p.111567-111567, Article 111567

2022

Volltextzugriff (PDF)

New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism

Drug design, development and therapy, 2022-08, Vol.16, p.2497-2507

2022

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

Nur zeigenMit Volltextzugriff

ThemaPatients

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CT-based muscle and adipose measurements predict prognosis in patients with digestive system malignancy

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients

Nutritional features-based clustering analysis as a feasible approach for early identification of malnutrition in patients with cancer

Development and validation of an inflammatory biomarkers model to predict gastric cancer prognosis: a multi-center cohort study in China

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists

Mid-Arm Muscle Circumference or Body Weight-Standardized Hand Grip Strength in the GLIM Superiorly Predicts Survival in Chinese Colorectal Cancer Patients

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice

Triceps skinfold–albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial

Zinc deficiency exacerbates diabetic down-regulation of Akt expression and function in the testis: essential roles of PTEN, PTP1B and TRB3

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

High Visceral Fat in Female Breast Cancer Patients Correlates with the Risk of Progression after Adjuvant Chemotherapy

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

The clinical application value of the extracellular-water-to-total-body-water ratio obtained by bioelectrical impedance analysis in people with advanced cancer

Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial

New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism

Aktive Filter

Suchergebnisse filtern